相关实验视频

Updated: May 3, 2026

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

用于指导放射瘤学家在DCIS管理中的工具

Maria Cristina Leonardi¹, Maria Alessia Zerella¹, Matteo Lazzeroni²

¹Division of Radiation Oncology, IEO, European Institute of Oncology IRCCS, 20141 Milan, Italy.

Healthcare (Basel, Switzerland)

|April 13, 2024

概括

管道癌在现场 (DCIS) 管理正在向个性化放射治疗发展. 需要一个全面的框架来指导瘤学家的决策,平衡风险因素和患者沟通,以便做出明智的选择.

科学领域:

在瘤学瘤学.
辐射瘤学辐射瘤学
乳腺癌研究研究乳腺癌研究

背景情况:

管道癌在位 (DCIS) 管理正在从通用放射治疗转向个性化策略.
缺乏全面的框架阻碍了放射瘤学家对DCIS治疗的决策过程.
对风险因素的主观解释和风险感知使治疗计划复杂化.

研究的目的:

审查关于管理DCIS的当前知识.
为放射瘤学家在DCIS治疗中强调可用的工具.
提供关于DCIS管理未来发展的前景.

主要方法:

对当前文献和数据进行叙述性审查.
分析DCIS中不断变化的治疗模式.
综合关于风险评估和患者沟通的信息.

主要成果:

高质量的数据正在成熟,为DCIS管理提供了洞察力.
包括放弃放射治疗在内的个性化方法正在出现.
有效的患者-提供者沟通对于明智的决策至关重要.

结论:

放射性瘤学家需要更好的工具和框架来管理DCIS.
未来的发展旨在完善风险分层和个性化治疗策略.
在DCIS护理中,平衡瘤安全与患者福祉至关重要.

关键词:

乳腺癌乳腺癌乳腺癌管道癌 in situ 的情况.当地复发局部复发管理的管理管理的管理.辐射疗法辐射疗法

更多相关视频

Intraductal Delivery to the Rabbit Mammary Gland

Intraductal Delivery to the Rabbit Mammary Gland

Published on: March 9, 2017

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

相关概念视频

Cancer Survival Analysis

Cancer Survival Analysis

Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...